More 2019 speakers to be announced shortly.
(alphabetical by last name)

Ismail Ali, JD
Policy & Advocacy Counsel, MAPS
“Mystical Momentum: the Challenges and Opportunities of Decriminalizing Psychedelics”
Speaking Sunday, October 13th, 2019

Shannon Carlin, M.A., AMFT
Associate Director of Training and Supervision,
MAPS Public Benefit Corporation
Class instructor for “Introduction to MDMA Therapy for Clinicians”

Caledonia Curry aka SWOON
Artist and Activist
”Unearthing The Medea: The Intersection of Art and Psychedelic Assisted Therapy”
Speaking Sunday, October 13th, 2019

Elias Dakwar, Ph.D.
Associate Professor of Psychiatry, Columbia University
Ketamine and Psychiatry
Speaking Saturday, October 12th, 2019

Alan Davis, Ph.D.
Clinical Psychologist, The Ohio State University & Johns Hopkins University
“The Potential for Healing and Harm with 5-MeO-DMT”
Speaking Saturday, October 12th, 2019

Will Van Derveer, MD
Medical Director, Integrative Psychiatric Healing Hospital
Assistant Clinical Professor,
University of Colorado School of Medicine
Class instructor for “Introduction to Ketamine Therapy”

Charlotte Harrison
Clinical Trial Leader, MAPS Public Benefit Corporation
Update on MAPS MDMA for PTSD clinicals trials
Speaking Saturday, October 12th, 2019

Carl Hart, Ph.D
Ziff Professor of Psychology (in Psychiatry), Departments of Psychology and Psychiatry, Columbia University
Stop Medicalizing the Pursuit of Happiness
Speaking Saturday, October 12th, 2019

Julie Holland, M.D.
Psychiatrist and Author
Science & Medicine Program Host & Moderator
Speaking Saturday, October 12th, 2019

Kim Kuypers, Ph.D.
Researcher and Assistant Professor, Maastricht University, The Netherlands
LSD microdosing study: Psychedelics and behavioral effects: What’s in a dose?
Speaking Saturday, October 12th, 2019

Taylor Lyons, Ph.D. (cand)
Postgraduate Researcher, Psychedelic Research Group, Imperial College, London, UK
Neuroscience findings from psilocybin neuroimaging studies
Speaking Saturday, October 12th, 2019

Marcela Ot'alora G., MFA, MA, LPC
Psychotherapist and Principal Investigator
MAPS MDMA-Assisted Psychotherapy Research Program
Class instructor for “Introduction to MDMA Therapy for Clinicians”

William A. Richards, Ph. D.
Author and Psychologist
Johns Hopkins School of Medicine
Class instructor for “Introduction to Psilocybin Therapy”

Rosalind Watts, Ph.D.
Clinical Psychologist, Psychedelic Research Group,
Imperial College, London, UK
Psilocybin therapy for treatment of depression
Speaking Saturday, October 12th, 2019

Malynn Utzinger, M.D.
Director of Integrative Medicine, Co-Founder, Usona Institute
Director of Integrative Practices, Promega Corporation
Clinical trials on psilocybin as a treatment for major depressive disorder
Speaking Saturday, October 12th, 2019

More 2019 speakers to be announced shortly.


Biographies & Abstracts